Lacking CCR2 solely on tumor microenvironmental cells leads to enhanced tumor progression, whereby high numbers of GAMs infiltrate gliomas independently of the CCR2/CCL2 signal [47]. The gene discussed is CCR2; the disease is central nervous system cancer.